Publications To Date


    Filter Publications

    PAGE 1 OF 40 | DISPLAYING 1 - 15 OF 588 RESULTS

    Zalfa F. et al., The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells, 10.1038/cddis.2017.521, Cell Death and Diff., Nov 16, 2017

    Naidu S. et al., PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways, 10.1038/s41598-017-14843-6, Sci. Reports, Nov 13, 2017

    Zhang J. et al., Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer., 10.1002/cncr.31062, Cancer, Nov 07, 2017

    Lampis A. et al., MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma, 10.1053/j.gastro.2017.10.043, Gatroenterology, Nov 04, 2017

    Giridhar K.V. et al., Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma., 10.3390/ijms18112326., In. J. Mol. Sci., Nov 03, 2017

    Grenga I. et al., Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis, 10.1016/j.urolonc.2017.09.027, Urologic Oncology, Nov 02, 2017

    Saurer L. et al., TREM-1 promotes intestinal tumorigenesis, 10.1038/s41598-017-14516-4, Sci. Reports, Nov 01, 2017

    Leonard K.M. et al., Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma, 10.1038/labinvest.2017.108, Lab Invest., Oct 30, 2017

    Patil N.S. et al., Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma., 10.1016/j.jtho.2017.09.1968, J. Thorac. Oncol., Oct 24, 2017

    Denaro M. et al., Differences in miRNA expression profiles between wild-type and mutated NIFTPs., 10.1530/ERC-17-0167., Endocr Relat Cancer. , Oct 24, 2017

    Das K. et al., Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial., 10.1016/j.canlet.2017.10.011, Cancer Lett., Oct 20, 2017

    Hequet D. et al., Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers., 10.1371/journal.pone.0185753., PLoS ONE, Oct 18, 2017

    Bailey F.P. et al., Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics, 10.1111/pcmr.12650, Pigment Cell and Melanoma, Oct 15, 2017

    McRee A.J. et al., A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer, 10.1016/j.clbc.2017.10.014, Clin. Breast Can., Oct 14, 2017

    Lawler K Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study, 10.1186/s13058-017-0881-y, Breast Cancer Res., Oct 13, 2017